dr. marks on the role of tkis in her2-positive breast cancer
Published 5 years ago • 351 plays • Length 0:57Download video MP4
Download video MP3
Similar videos
-
1:50
dr. rimawi discusses role of tkis in her2 breast cancer
-
5:46
treating her2 mbc: immunotherapy and tkis
-
9:38
role of t-dm1 in her2-positive metastatic breast cancer
-
13:18
role of lapatinib in her2-positive breast cancer
-
2:03
dr. marks on investigational antibody-drug conjugates in her2 breast cancer
-
1:22
dr. pegram on challenges facing the treatment of her2-positive breast cancer
-
1:35
dr. sanft on treatment options in her2-positive breast cancer
-
1:53
dr. pegram on pertuzumab combination for her2-positive breast cancer
-
6:01
treating low-risk her2-positive breast cancer
-
1:21
dr. louis weiner discusses the t-dm1 emilia trial for her2-positive breast cancer
-
3:52
case study: her2-positive oligometastatic breast cancer
-
14:17
anti-human epidermal growth factor receptor 2 (her2) treatments in breast cancer
-
3:48
her2 breast cancer: future treatment landscape
-
1:30
dr. hope rugo on trastuzumab biosimilar in her2-positive breast cancer
-
1:37
dr. bhave on promising anti-her2 agents in her2 breast cancer
-
0:49
dr. o’regan on prognostic value of pcr in her2 breast cancer
-
4:33
upfront t-dm1 in her2-positive breast cancer
-
1:57
dr. dietrich on adverse event management for neratinib in breast cancer
-
1:55
dr. hurvitz on novel emerging agents in her2 breast cancer